Course info

This activity is intended for Physicians, PAs, Pharmacists, Nurses, APRNs, Psychologists, Social Workers, Dentists and other healthcare providers who care for patients with substance use disorders or an infectious diseases(s).

Upon completion of this activity, participants should be able to:

Social Justice/Language Justice

• Describe the impact of language and barriers to accessing services

• Identify best practices for integrating language justice into service provisions

• Describe the current environment of community relations

• Describe best practices for engaging the community regarding drug user health

National Perspectives on Harm Reduction and Community Health

• Explain the national harm reduction efforts and initiatives contribution to promoting community health

• Describe harm reduction’s role in addressing public health challenges at the national level, such as substance use disorders and infectious diseases

• Identify practical strategies and best practices in harm reduction that individuals and communities can implement to reduce harm, improve access to healthcare, and build stronger communities

• Describe gaps in services needed to address the overdose crisis

• Discuss harm reduction as a strategic model for addressing the overdose crisis

Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm

• Recognize the political impact on harm reduction and the current environment

• Recognize harm reduction as a national public health issue

• Identify priorities and effective advocacy strategies for harm reduction policies nationally

• Describe successful models and lessons learned from harm reduction initiatives in Washington DC

• Identify successful models and lessons from harm reduction initiatives in Washington DC

Drug User Health in a Syndemic Environment

• Describe impact of living in a syndemic environment on overall quality of life

• Describe best practices for advocating for clients to address whole person health

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies: 

Ken Pettigrew Director of Capacity Building HealthHIV has no relevant financial relationship(s) with ineligible companies to disclose 

Leo Sheridan Capacity Building Manager has no relevant financial relationship(s) with ineligible companies to disclose 

Mark Robinson Regional Syringe Service Program Manager Family and Medical Counseling Service, Inc. has no relevant financial relationship(s) with ineligible companies to disclose 

Ashley Elliott, MD Clinical Psychologist & Mental Health Consultant Vivid Innovations Consulting has no relevant financial relationship(s) with ineligible companies to disclose 

Sonia Canzater, JD, MPH Associate Director, Infectious Diseases Initiative O’Neill Institute for National and Global Health Law, Georgetown University Law Center has no relevant financial relationship(s) with ineligible companies to disclose 

Brian Corry Public Health Advisor Division of Overdose Prevention has no relevant financial relationship(s) with ineligible companies to disclose 

Jenna Bluestein Advisor, Office of Public Health and the Office of National Drug Control Policy (ONDCP) has no relevant financial relationship(s) with ineligible companies to disclose 

William McColl Founder and Owner McColl Strategies, LLC has no relevant financial relationship(s) with ineligible companies to disclose 

Irene Kuo, PhD, MPH Associate Research Professor George Washington University Milken Institute School of Public Health Has no relevant financial relationship(s) with ineligible companies to disclose 

George S. Kerr III, MT-CDSMP/DM Founder/CEO G III Associates has no relevant financial relationship(s) with ineligible companies to disclose 

Leslie Demus Unity Healthcare has no relevant financial relationship(s) with ineligible companies to disclose 

The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The HealthHIV planners and others have no relevant financial relationship(s) to disclose with ineligible companies.

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and HealthHIV. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PACE designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.25 contact hours.

PACE designates this continuing education activity for 3.25 contact hour(s) (0.325 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. 

This activity is designated for 3.25 AAPA Category 1 CME credits. Approval is valid until August 28, 2024. PAs should only claim credit commensurate with the extent of their participation.

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. 

Credit Designation 

This program offers 3.25 continuing education credits for psychologists.

As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 3.25 clinical, cultural competency or general* continuing education credits. 

*Social Justice/Language Justice – cultural competency
National Perspectives on Harm Reduction and Community Health – general
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm – general
Drug User Health in a Syndemic Environment – clinical

PACE designates this activity for 3.25 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.